Evaluating Chlamydia trachomatis and Neisseria
gonorrhoeae screening among asymptomatic pregnant women to prevent
preterm birth and low birth weight in Gaborone, Botswana: A
non-randomized, cluster-controlled trial.
Authors: Dr. Adriane Wynn, PhD1,2; Ms. Aamirah
Mussa2,3; Dr. Rebecca Ryan,BMBCh2;
Dr. Chibuzor M. Babalola, MD4; Ms. Emily
Hansman5; Ms. Kehumile
Ramontshonyana2; Ms. Lefhela
Tamuthiba2; Ms. Neo Ndlovu2; Dr.
Melissa L. Wilson,PhD4; Dr. Doreen Ramogola-Masire,
MRCOG6; Dr. Jeffrey D. Klausner, MD,
MPH4; Dr. Chelsea Morroni, PhD,
MBChB2,7
Institutions:
1) University of California, San Diego, Division of Infectious Diseases
and Global Public Health, 9500 Gilman Drive, La Jolla, CA 92093 USA;
2) Botswana Harvard AIDS Institute Partnership, Princess Marina
Hospital, Plot No. 1836, Northring Road, Gaborone, Botswana;
3) Usher Institute, University of Edinburgh, Old Medical School, Teviot
Place, Edinburgh, EH8 9AG, United Kingdom;
4) Keck School of Medicine, University of Southern California, 1845 N.
soto Street, Health Sciences Campus, Los Angeles, California, 90033 USA;
5) David Geffen School of Medicine, University of California, Los
Angeles, 885 Tiverton Dr, Los Angeles, CA 90095 USA;
6) Department of Obstetrics and Gynaecology, University of Botswana, Sir
Ketumile Masire Teaching Hospital/G5038, Gaborone, Botswana;
7) MRC Centre for Reproductive Health, University of Edinburgh, The
Queen’s Medical Research Institute, Edinburgh BioQuarter, 47 Little
France Crescent, Edinburgh EH16 4TJ, United Kingdom
Corresponding author : Dr. Adriane Wynn; Email:
awynn@health.ucsd.edu;
Phone: 916-662-1497
Short Title : Asymptomatic STI screening to prevent adverse
birth outcomes